Systematic review of risk factors for nonadherence to TB treatment in immigrant populations

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 110, Issue 5, 2016, Pages 268-280

  Lin, Stephanie ^a   Melendez Torres, G J ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Emigrants and immigrants; Medication adherence; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; ISONIAZID PLUS RIFAMPICIN; PYRAZINAMIDE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AGE DISTRIBUTION; ANTIMICROBIAL THERAPY; ARTICLE; ASIA; AUSTRALIA; CANADA; CENTRALIZATION; EDUCATIONAL STATUS; ENGLAND; ETHNICITY; FAMILY; HEALTH CARE ACCESS; HIGH RISK BEHAVIOR; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMIGRANT; IMMIGRATION; INCIDENCE; INDIA; ITALY; MALAYSIA; MARRIAGE; MEXICO; MYANMAR; PATIENT COMPLIANCE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SEX DIFFERENCE; SOCIAL STATUS; SOUTH AND CENTRAL AMERICA; SPAIN; SUBSTANCE ABUSE; SWITZERLAND; SYSTEMATIC REVIEW; THAILAND; TIBET; TREATMENT REFUSAL; TUBERCULOSIS; UNDOCUMENTED IMMIGRANT; UNITED STATES; EUROPE; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MEDICATION COMPLIANCE; MIGRANT; MIGRATION; NORTH AMERICA;

ANTITUBERCULAR AGENTS; EMIGRANTS AND IMMIGRANTS; EMIGRATION AND IMMIGRATION; EUROPE; HUMANS; LATENT TUBERCULOSIS; MEDICATION ADHERENCE; NORTH AMERICA; RISK FACTORS; TUBERCULOSIS, PULMONARY;

EID: 84979009529     PISSN: 00359203     EISSN: 18783503     Source Type: Journal    
DOI: 10.1093/trstmh/trw025     Document Type: Article

References (43)

1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012;380:2095-128.
2. Reichman LB, Hershfield ES. Tuberculosis: A Comprehensive International Approach. 2nd ed. New York: Dekker; 2000.
3. Broekmans JF, Migliori GB, Rieder HL, et al. European framework for tuberculosis control and elimination in countries with a low incidence. Recommendations of the World Health Organization (WHO), International Union Against Tuberculosis and Lung Disease (IUATLD) and Royal Netherlands Tuberculosis As. Eur Respir J 2002; 19:765-75.
4. Rieder HL, Chen-Yuan C, Gie RP, et al. Clinical Tuberculosis. 3rd ed. Oxford: Macmillan Publishers, Disease, International Union Against Tuberculosis and Lung Disease, 2009.
5. WHO. Treatment of Tuberculosis: Guidelines. 4th ed. Geneva: World Health Organization; 2010. http://www.ncbi.nlm.nih.gov/books/ NBK138748/ [accessed 17 March 2016].
6. WHO. Global Tuberculosis Report 2013. Geneva: World Health Organization; 2013. http://apps.who.int/iris/bitstream/10665/91355/ 1/9789241564656_eng.pdf [accessed 17 March 2016].
7. Tankimovich M. Barriers to and interventions for improved tuberculosis detection and treatment among homeless and immigrant populations: a literature review. J Community Health Nurs 2013;30: 83-95.
8. O'Mara A, Marrero-Guillamon I, Jamal F, et al. Tuberculosis Evidence Review 1: Review of Barriers and Facilitators, 2010. http://www.nice. org.uk/nicemedia/live/11978/56315/56315.pdf [accessed 2 December 2013].
9. Abarca Tomás B, Pell C, Bueno Cavanillas A, et al. Tuberculosis in migrant populations. A systematic review of the qualitative literature. PLoS One 2013;8:e82440.
10. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantiative review of 50 years of research. Med Care 2004;42:200-9.
11. Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
12. Fazel M, Wheeler J, Danesh J. Prevalence of serious mental disorder in 7000 refugees resettled in western countries: a systematic review. Lancet 2005;365:1309-14.
13. Peñaloza B, Pantoja T, Bastías G, et al. Interventions to reduce emigration of health care professionals from low- and middle-income countries. Cochrane Database Syst Rev 2011:CD007673.
14. Rueda S, Park-Wyllie LY, Bayoumi AM, et al. Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database Syst Rev 2006:CD001442.
15. Waterman H, Evans JR, Gray TA, et al. Interventions for improving adherence to ocular hypotensive therapy. Cochrane Database Syst Rev 2013;4:CD006132.
16. Bain-Brickley D, Butler LM, Kennedy GE, et al. Interventions to improve adherence to antiretroviral therapy in children with HIV infection. Cochrane Database Syst Rev 2011:CD009513.
17. Critical Appraisal Skills Programme. Cohort Study Checklist. Oxford: Critical Appraisal Skills Programme (CASP); 2013. http://media.wix.com/ ugd/dded87_e37a4ab637fe46a0869f9f977dacf134.pdf [accessed 14 April 2016].
18. Arai SR. Migration-related tuberculosis among Asian immigrants in San Francisco: treatment outcomes, 1994-1998. Dissertation for Doctor of Philosophy in Nursing at the University of California, San Francisco; 2005.
19. Murray J, Farrington D, Eisner M. Drawing conclusions about causes from systematic reviews of risk factors: The Cambridge Quality Checklists. J Exp Criminol 2009;5:1-23.
20. Brassard P, Steensma C, Cadieux L, et al. Evaluation of a schoolbased tuberculosis-screening program and associate investigation targeting recently immigrated children in a low-burden country. Pediatrics 2006;117:e148-56.
21. Coly A, Morisky D. Predicting completion of treatment among foreign-born adolescents treated for latent tuberculosis infection in Los Angeles. Int J Tuberc Lung Dis 2004;8:703-10.
22. Minodier P, Lamarre V, Carle M-E, et al. Evaluation of a school-based program for diagnosis and treatment of latent tuberculosis infection in immigrant children. J Infect Public Health 2010;3:67-75.
23. Nelson LJ, Naik Y, Tsering K, et al. Population-based risk factors for tuberculosis and adverse outcomes among Tibetan refugees in India, 1994-1996. Int J Tuberc Lung Dis 2005;9:1018-26.
24. Ailinger RL, Dear MR. Adherence to tuberculosis preventive therapy among Latino immigrants. Public Health Nurs 1998;15:19-24.
25. Ailinger RL, Black P, Nguyen N, et al. Predictors of adherence to latent tuberculosis infection therapy in Latino immigrants. J Community Health Nurs 2007;24:191-8.
26. Codecasa LR, Murgia N, Ferrarese M, et al. Isoniazid preventive treatment: predictors of adverse events and treatment completion. Int J Tuberc Lung Dis 2013;17:903-8.
27. Minetti A, Camelique O, Hsa Thaw K, et al. Tuberculosis treatment in a refugee and migrant population: 20 years of experience on the Thai-Burmese border. Int J Tuberc Lung Dis 2010;14:1589-95.
28. Mitruka K, Winston C, Navin TR. Predictors of failure in timely tuberculosis treatment completion, United States. Int J Tuberc Lung Dis 2012;16:1075-82.
29. Trauer JM, Krause VL. Assessment and management of latent tuberculosis infection in a refugee population in the Northern Territory. Med J Aust 2011;194:579-82.
30. Jiménez-Fuentes MA, de Souza-Galvao ML, Mila Augé C, et al. Rifampicin plus isoniazid for the prevention of tuberculosis in an immigrant population. Int J Tuberc Lung Dis 2013;17:326-32.
31. Sanz B, Blasco T. Variables associated with diagnostic delay in immigrant groups with tuberculosis in Madrid. Int J Tuberc Lung Dis 2007;11:639-46.
32. Ailinger RL, Moore JB, Nguyen N, et al. Adherence to latent tuberculosis infection therapy among latino immigrants. Public Health Nurs 2006;23:307-13.
33. Scotto G, Fornabaio C, Prato R, et al. Tuberculosis and immigrants: a SIMIT (Italian Society of Infectious Diseases) clinical, epidemiological multicentric research investigation. New Microbiol 2009;32:39-47.
34. Cegolon L, Maguire H, Mastrangelo G, et al. Predictors of failure to complete tuberculosis treatment in London, 2003-2006. Int J Tuberc lung Dis 2010;14:1411-7.
35. Helbling P, Medinger C, Altpeter E, et al. Outcome of treatment of pulmonary tuberculosis in Switzerland in 1996. Swiss Med Wkly 2002;132:517-22.
36. Kapella BK, Anuwatnonthakate A, Komsakorn S, et al. Directly observed treatment is associated with reduced default among foreign tuberculosis patients in Thailand. Int J Tuberc Lung Dis 2009;13:232-7.
37. Lake IR, Jones NR, Bradshaw L, et al. Effects of distance to treatment centre and case load upon tuberculosis treatment completion. Eur Respir J 2011;38:1223-5.
38. Nissapatorn V, Kuppusamy I, Wan-Yusoff WS, et al. Clinical analysis of foreign-born patients with tuberculosis found in Malaysia. Southeast Asian J Trop Med Public Health 2005;36:713-21.
39. Orr PH, Manfreda J, Hershfield ES. Tuberculosis surveillance in immigrants to Manitoba. Can Med Assoc J 1990;142:453-8.
40. Breuss E, Helbling P, Altpeter E, et al. Screening and treatment for latent tuberculosis infection among asylum seekers entering Switzerland. Swiss Med Wkly 2002;132:197-200.
41. Home Office. UK Border Agency. Central Policy Unit. Screening for Tuberculosis and the Immigration Control: UK Border Agency Review of Current Screening Activity 2011. London: UK Border Agency; 2011. https://www.gov.uk/government/uploads/system/uploads/attachment_ data/file/117948/tb-screening-review.pdf [accessed 17 March 2016].
42. Kraemer H, Kraemer-Lowe K, Kupfer D. To Your Health: How to Understand What Research Tells Us about Risk. New York: Oxford University Press; 2005.
43. Gellad WF, Grenard J, McGlynn EA. A Review of Barriers to Medication Adherence: A Framework for Driving Policy Options. Santa Monica: RAND Corporation; 2009. http://www.rand.org/pubs/technical_reports/ TR765.html [accessed 20 May 2014].